We do not publish a verdict for SBC Medical Group Holdings Inc (SBC) and Verisk Analytics Inc (VRSK) is overvalued.
We publish an intrinsic value for VRSK but not for SBC, so the two cannot be ranked on price.
Values as of the 19 Oct 2026 close.
We do not publish a value for this company: its filings cover three fiscal years and projecting growth needs four in a row.
Leak Score 84/100 on 6 of 12 signals
Discounting its cash flows at 8.5% (average of 3 methods) values the shares at $151.47; the price of $189.21 is 25% above that value, and 78% of that value comes from beyond year five.
Leak Score 64/100 on 11 of 12 signals
| Metric | SBC | VRSK |
|---|---|---|
| Verdict | Not valued | Overvalued |
| Price | $5.36 | $189.21 |
| Intrinsic value | — | $151.47 |
| Margin of safety | — | -25% |
| Leak Score | 84/100 (6/12) | 64/100 (11/12) |
| Market cap | $551M | $24.6B |
| Revenue growth, 5 years | — | 2.0% |
| Operating margin | 37.3% | 44.8% |
| Net margin | 28.0% | 28.2% |
| Return on equity | 19.3% | 444.1% |
| Debt to equity | 0.18 | — |
| P/E | 11.2x | 29.1x |
| Forward P/E | 10.3x | 21.8x |
| P/B | 2.1x | — |
| Dividend yield | — | 1.1% |